CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Sangro, Bruno [1 ,2 ]
Hsu, Chiun [3 ]
Kang, Yoon-Koo [4 ]
Kim, Tae-You [5 ]
El-Khoueiry, Anthony [6 ]
Santoro, Armando [7 ]
Melero, Ignacio [8 ]
Kudo, Masatoshi [9 ]
Hou, Ming-Mo [10 ]
Pena, Ana Matilla [11 ]
Tovoli, Francesco [12 ]
Knox, Jennifer J. [13 ]
He, Aiwu Ruth [14 ]
El-Rayes, Bassel [15 ]
Acosta, Mirelis Rivera [16 ]
Lim, Ho-Yeong [17 ]
Neely, Jaclyn [18 ]
Zhao, Huanyu [18 ]
Anderson, Jeffrey [18 ]
Yau, Thomas [19 ]
机构：
[1] Clin Univ Navarra, Idisna, Pamplona, Spain
[2] Ciberehd, Madrid, Spain
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Univ Ulsan, Asan Med Ctr, Ulsan, South Korea
[5] Seoul Natl Univ, Seoul, South Korea
[6] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[7] Humanitas Univ, Humanitas Clin & Res Ctr, Rozzano, Italy
[8] Univ Navarra, Pamplona, Spain
[9] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Higashiosaka, Osaka, Japan
[10] Chang Gung Mem Hosp, Taipei, Taiwan
[11] Hosp Gen Univ Gregorio Maranon, Serv Digest, Madrid, Spain
[12] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[13] Princess Margaret Canc Ctr, Toronto, ON, Canada
[14] Georgetown Univ Hosp, Washington, DC 20007 USA
[15] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[16] Fdn Invest, San Juan, PR USA
[17] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[18] Bristol Myers Squibb, New York, NY USA
[19] Univ Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
200
引用
下载
收藏
页码：131A / 132A
页数：2
相关论文
共 50 条
  • [21] Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040
    Sangro, Bruno
    Melero, Ignacio
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Kim, Tae-You
    Choo, Su-Pin
    Trojan, Jorg
    Welling, Theodore H.
    Meyer, Timothy
    Kang, Yoon-Koo
    Yeo, Winnie
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Neely, Jaclyn
    Crocenzi, Todd S.
    El-Khoueiry, Anthony B.
    HEPATOLOGY, 2017, 66 : 82A - 82A
  • [22] HEPATIC SAFETY AND BIOMARKER ASSESSMENTS IN SORAFENIB-EXPERIENCED PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH NIVOLUMAB IN THE CHECKMATE-040 STUDY
    Crocenzi, Todd
    Meyer, Tim
    Melero, Ignacio
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Choo, Su-Pin
    Trojan, Jorg
    Welling, Theodore
    Kang, Yoon-Koo
    Yeo, Winnie
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Neely, Jaclyn
    El-Khoueiry, Anthony
    Sangro, Bruno
    GASTROENTEROLOGY, 2018, 154 (06) : S1234 - S1234
  • [23] Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study
    Melero, I.
    Sangro, B.
    Yau, T.
    Hsu, C.
    Kudo, M.
    Crocenzi, T.
    Kim, T-Y.
    Choo, S. P.
    Trojan, J.
    Meyer, T.
    Welling, T. H., III
    Yeo, W.
    Chopra, A.
    Anderson, J.
    Dela Cruz, C.
    Lang, L.
    Neely, J.
    El-Khoueiry, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Assessment of inflammation biomarkers in relation to clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma in CheckMate 040
    Melero, Ignacio
    Neely, Jaclyn
    Sangro, Bruno
    Finn, Richard
    Abou-Alfa, Ghassan K.
    Cheng, Ann-Lii
    Yau, Thomas
    Furuse, Junji
    Park, Joong-Won
    Wadhawan, Samir
    Tang, Hao
    Delacruz, Christine
    Baccan, Carlos
    Boyd, Zach
    El-Khoueiry, Anthony
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)
    Tawbi, Hussein A.
    Forsyth, Peter A.
    Hodi, F. Stephen
    Lao, Christopher D.
    Moschos, Stergios J.
    Hamid, Omid
    Atkins, Michael B.
    Lewis, Karl
    Thomas, Reena P.
    Glaspy, John A.
    Jang, Sekwon
    Algazi, Alain P.
    Khushalani, Nikhil, I
    Postow, Michael A.
    Pavlick, Anna C.
    Ernstoff, Marc S.
    Reardon, David A.
    Puzanov, Igor
    Kudchadkar, Ragini R.
    Tarhini, Ahmad A.
    Sumbul, Anne
    Rizzo, Jasmine, I
    Margolin, Kim A.
    NEURO-ONCOLOGY, 2021, 23 (11) : 1961 - 1973
  • [26] Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
    Hammers, Hans J.
    Plimack, Elizabeth R.
    Infante, Jeffrey R.
    Rini, Brian I.
    McDermott, David F.
    Lewis, Lionel D.
    Voss, Martin H.
    Sharma, Padmanee
    Pal, Sumanta K.
    Razak, Albiruni R. Abdul
    Kollmannsberger, Christian
    Heng, Daniel Y. C.
    Spratlin, Jennifer
    McHenry, M. Brent
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3851 - +
  • [27] Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)
    Hodi, F. Stephen
    Chapman, Paul B.
    Sznol, Mario
    Lao, Christopher D.
    Gonzalez, Rene
    Smylie, Michael
    Daniels, Gregory A.
    Thompson, John A.
    Kudchadkar, Ragini
    Sharfman, William
    Atkins, Michael
    Spigel, David R.
    Pavlick, Anna
    Monzon, Jose
    Kim, Kevin B.
    Ernst, Scott
    Khushalani, Nikhil, I
    van Dijck, Wim
    Lobo, Maurice
    Hogg, David
    MELANOMA RESEARCH, 2021, 31 (01) : 67 - 75
  • [28] Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).
    Tawbi, Hussein Abdul-Hassan
    Forsyth, Peter A. J.
    Hodi, F. Stephen
    Lao, Christopher D.
    Moschos, Stergios J.
    Hamid, Omid
    Atkins, Michael B.
    Lewis, Karl D.
    Thomas, Reena Parada
    Glaspy, John A.
    Jang, Sekwon
    Algazi, Alain Patrick
    Khushalani, Nikhil I.
    Postow, Michael A.
    Pavlick, Anna C.
    Ernstoff, Marc S.
    Reardon, David A.
    Balogh, Agnes
    Rizzo, Jasmine I.
    Margolin, Kim Allyson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Nivolumab dose escalation and expansion in patients with advanced hepatocellular carcinoma (HCC): The CheckMate 040 study.
    Melero, Ignacio
    Sangro, Bruno
    Yau, Thomas Cheung
    Hsu, Chiun
    Kudo, Masatoshi
    Crocenzi, Todd S.
    Kim, Tae-You
    Choo, SuPin
    Trojan, Jorg
    Meyer, Tim
    Welling, Theodore Hobart
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    Dela Cruz, Christine Marie
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    El-Khoueiry, Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [30] Nivolumab in sorafenib-naive and - experienced patients with advanced hepatocellular carcinoma (HCC): checkMate 040 study
    Trojan, J.
    Crocenzi, T. S.
    El-Khoueiry, A. B.
    Yau, T.
    Melero, I.
    Sangro, B.
    Kudo, M.
    Hsu, C.
    Kim, T. -Y.
    Choo, S. -P.
    Meyer, T.
    Kang, Y. -K.
    Yeo, W.
    Chopra, A.
    Baakili, A.
    dela Cruz, C.
    Lang, L.
    Neely, J.
    Welling, T. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 210 - +
12345